ECO Animal Health Group Adjusts Valuation Amid Declining Net Profit and Rising Interest

ECO Animal Health Group Plc, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the company's valuation score, moving from a classification of very expensive to expensive. Key financial metrics indicate that the stock's P/E ratio stands at 12, while the Price to Book Value is noted at 0.70. The company’s EV to EBIT and EV to EBITDA ratios are recorded at 6.26 and 4.36, respectively. Additionally, the EV to Sales ratio is 0.48, and the PEG ratio is reported at 0.08. Despite a low Return on Equity (ROE) of 6.07%, ECO Animal Health has demonstrated a fair valuation. The company has experienced a notable return of 37.41% over the past year, significantly outpacing the FTSE 100's return of 17.30%. However, the latest quarter ending March 2026 showed a decline in net profit by 25.36%, alongside a substantial growth in interest. For more insights on ECO Animal Health Group Plc, including the latest Mojo Score and financial trend performance, visit: Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.